A systematic comparison of Cockcroft-Gault and modification of diet in renal disease equations for classification of kidney dysfunction and dosage adjustment;Una comparación sistemática de las ecuaciones de Cockcroft-Gault y modificacion de dieta en la enfermedad renal (MDRD) para la clasificación de disfunción renal y ajuste de dosis

Annals of Pharmacotherapy

Volumn 46, Issue 9, 2012, Pages 1174-1187

  Park, Eun Jung ^a   Wu, Kunyi ^a   Mi, Zenghui ^a   Dong, Ting ^a   Lawrence, John P ^a   Ko, Chia Wen ^a   Huang, Shiew Mei ^a   Zhang, Lei ^a   Crentsil, Victor ^a   Zhang, Jialu ^a   Xu Dr , Nancy N ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Advanced age; Cockcroft Gault; Dosing; Modification of diet in renal disease; Pharmacokinetics; Standardized serum creatinine assay

Indexed keywords

4 AMINOPYRIDINE; DAPTOMYCIN; DARIFENACIN; DESVENLAFAXINE; EMTRICITABINE; ENTECAVIR; EPTIFIBATIDE; ESZOPICLONE; FESOTERODINE; GEMIFLOXACIN; HARKOSERIDE; IBANDRONIC ACID; MEMANTINE; MILNACIPRAN; PALIPERIDONE; PITAVASTATIN; PLERIXAFOR; PREGABALIN; RALTEGRAVIR; ROSUVASTATIN; SAXAGLIPTIN; SILODOSIN; SITAGLIPTIN; SOLIFENACIN; TELAVANCIN; TELBIVUDINE; TELITHROMYCIN; TROSPIUM CHLORIDE; UNINDEXED DRUG; VARDENAFIL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY SURFACE; BODY WEIGHT; COCKCROFT GAULT EQUATION; CREATININE URINE LEVEL; DOSE CALCULATION; DOSE KIDNEY FUNCTION RELATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; FEMALE; GROUPS BY AGE; HUMAN; INTERMETHOD COMPARISON; KIDNEY CLEARANCE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MODIFICATION OF DIET IN RENAL DISEASE EQUATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; AREA UNDER CURVE; DATABASES, FACTUAL; DIET; DRUG DOSAGE CALCULATIONS; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; YOUNG ADULT;

EID: 84865839777     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q757     Document Type: Article

References (31)

1. National Kidney Foundation. The facts about chronic kidney disease (CKD). 2011. http://www.kidney.org/kidneydisease/ckd/index.cfm (accessed 2011 Sept 27).
2. Huang SM, Temple R, Xiao S, Zhang L, Lesko LJ. When to conduct a renal impairment study during drug development: US Food and Drug Administration perspective. Clin Pharmacol Ther 2009;86:475-9. doi: 10.1038/clpt.2009.190
3. Atkinson AJ Jr, Huang SM. Nephropharmacology: drugs and the kidney. Clin Pharmacol Ther 2009;86:453-6. doi: 10.1038/clpt.2009.191
4. Stevens LA, Nolin TD, Richardson MM, et al. Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis 2009;54:33-42. doi: 10.1053/j.ajkd.2009.03.008
5. Stevens LA, Levey AS. Use of the MDRD study equation to estimate kidney function for drug dosing. Clin Pharmacol Ther 2009;86:465-7. doi: 10.1038/clpt.2009.124
6. Food and Drug Administration Guidance to Industry. Pharmacokinetics in patients with impaired renal function-study design, data analysis, and impact on dosing and labeling. United States Department of Health and Human Services, Food and Drug Administration, 1998. http://www.fda.gov/ucm/groups/fdagov-public/@fdagov-drugs-gen/documents/document/ucm072127.pdf (accessed 2011 Sept 27).
7. Miller WG, Myers GL, Ashwood ER, et al. Creatinine measurement: state of the art in accuracy and interlaboratory harmonization. Arch Pathol Lab Med 2005;129:297-304.
8. National Kidney Foundation. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. 2000. http://www.kidney.org/professionals/kdoqi/guidelines_ckd/p4_class_g1.htm (accessed 2011 Sept 27).
9. NKDEP. Chronic kidney disease and drug dosing: information for providers. National Kidney Disease Education Program. Last revised January 27, 2011. http://www.nkdep.nih.gov/professionals/drug-dosinginformation.htm (accessed 2011 Sept 27).
10. Nyman HA, Dowling TC, Hudson JQ, Peter WL, Joy MS, Nolin TD. Comparative evaluation of the Cockcroft-Gault equation and the Modification of Diet in Renal Disease (MDRD) study equation for drug dosing: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy 2011;31: 1130-44. doi: 10.1592/phco.31.11.1130
11. Spruill WJ, Wade WE, Cobb HH III. Continuing the use of the Cockcroft-Gault equation for drug dosing in patients with impaired renal function. Clin Pharmacol Ther 2009;86:468-70. doi: 10.1038/clpt.2009.187
12. Wargo KA, Eiland EH III, Hamm W, English TM, Phillippe HM. Comparison of the modification of diet in renal disease and Cockcroft-Gault equations for antimicrobial dosage adjustment. Ann Pharmacother 2006; 40:1248-53. doi: 10.1345/aph.1G635
13. Wade WE, Spruill WJ. New serum creatinine assay standardization: implications for drug dosing. Ann Pharmacother 2007;41:475-80. doi: 10.1345/aph.1H586
14. Spruill WJ, Wade WE, Cobb HH III. Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function. Am J Geriatr Pharmacother 2008;6:153-60. doi: 10.1016/j.amjopharm.2008.07.002
15. Moranville MP, Jennings HR. Implications of using Modification of Diet in Renal Disease versus Cockcroft-Gault equations for renal dosing adjustments. Am J Health Syst Pharm 2009;66:154-61. doi: 10.2146/ajhp080071
16. Melloni C, Peterson ED, Chen AY, et al. Cockcroft-Gault versus Modification of Diet in Renal Disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 2008;51:991-6. doi: 10.1016/j.jacc.2007.11.045
17. Gouin-Thibault I, Pautas E, Mahe I, et al. Is Modification of Diet in Renal Disease formula similar to Cockcroft-Gault formula to assess renal function in elderly hospitalized patients treated with low-molecular-weight heparin? J Gerontol A Biol Sci Med Sci 2007;62:1300-5. doi: 10.1093/gerona/62.11.1300
18. Gill J, Malyuk R, Djurdjev O, Levin A. Use of GFR equations to adjust drug doses in an elderly multi-ethnic group-a cautionary tale. Nephrol Dial Transplant 2007;22:2894-9. doi: 10.1093/ndt/gfm289
19. Denetclaw TH, Oshima N, Dowling TC. Dofetilide dose calculation errors in elderly associated with use of the Modification of Diet in Renal Disease equation. Ann Pharmacother 2011;45:e44. doi: 10.1345/aph.1Q159
20. Healy MF, Speroni KG, Eugenio KR, Murphy PM. Adjusting eptifibatide doses for renal impairment: a model of dosing agreement among various methods of estimating creatinine clearance. Ann Pharmacother 2012;46:477-83. doi: 10.1345/aph.1Q644
21. Matzke GR, Aronoff GR, Atkinson AJ Jr, et al. Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2011;80:1122-37. doi: 10.1038/ki.2011.322
22. Food and Drug Administration Clinical Pharmacology Guidances (Drugs). http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm064982.htm (accessed 2011 Sept 27).
23. Martin PD, Warwick MJ, Dane AL, Brindley C, Short T. Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers. Clin Ther 2003;25:2553-63. doi: 10.1016/S0149-2918(03)80316-8
24. Park EJ, Pai MPP, Dong T, et al. The influence of body size descriptors on the estimation of kidney function in normal weight, overweight, obese, and morbidly obese adults. Ann Pharmacother 2012;46:317-28. doi: 10.1345/aph.1Q374
25. Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. New York: Wiley, 2003.
26. McDowell M, Fryar C, Ogden C, Flegal K. Anthropometric reference data for children and adults: United States, 2003-2006. National Health Statistics report number 10, October 22, 2008. http://www.cdc.gov/nchs/data/nhsr/nhsr010.pdf (accessed 2011 Sept 27).
27. Waldmeier F, Glaenzel U, Wirz B, et al. Absorption, distribution, metabolism, and elimination of the direct renin inhibitor aliskiren in healthy volunteers. Drug Metab Dispos 2007;35:1418-28. doi: 10.1124/dmd.106.013797
28. Janssen I, Ross R. Linking age-related changes in skeletal muscle mass and composition with metabolism and disease. J Nutr Health Aging 2005; 9:408-19.
29. Loya AM, Gonzalez-Stuart A, Rivera JO. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study. Drugs Aging 2009;26:423-36. doi: 10.2165/00002512-200926050-00006
30. Pai MP, Nafziger AN, Bertino JS Jr. Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients. Antimicrob Agents Chemother 2011;55:4006-11. doi: 10.1128/AAC.00174-11
31. Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA 2010;303:242-49. doi: 10.1001/jama.2009.2012